Semduramicin

Star0

DB11545ExperimentalVet approvedSmall molecule

Semduramicin: Overview.

Formula / weight: C₄₅H₇₆O₁₆ · 873.087 g/mol (avg)
Code names: UK-61,689

Resolves to

Compound

UNIIP6VXL377WLCAS113378-31-7ChEMBLCHEMBL1207444KEGGD05820

Clinical / RWD

RxNorm1314385

Structure

InChIKeyWINSLRIENGBHSH-ASZYJFLUSA-NSMILES

[H][C@@]1(C[C@H](O[C@@]2([H])CC[C@H](OC)[C@@H](C)O2)[C@@]([H])(O1)[C@]1(C)CC[C@@]([H])(O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@]([H])(O2)[C@@H](C)[C@]2([H])O[C@](O)(CC(O)=O)[C@@H](C)[C@H](O)[C@H]2OC)O1)[C@@]1([H])O[C@](C)(O)[C@H](C)C[C@@H]1C

What you can answer from here — as of August 30, 2026

1Marketed productAcross 1 country and 1 labeller

10+ReferencesStructured and connected to the statements they support

Which companies are running trials of Semduramicin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account